关于中国老年人无抑郁症预期寿命的研究
Ruirui Xie1, Heting Wu2, Fei Zhao3
1School of Public Health, Shandong Second Medical University, No.7166 Baotong West Street, Weifang, 261053, Shandong, China.
BMC public health
|October 16, 2025
概括
患有中度至重度抑郁症的老年人经历了显著减少的预期寿命. 与农村同行相比,城市老年人有更长的无抑郁生活,突出了心理健康资源获取方面的差异.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 心理健康研究 心理健康研究
背景情况:
- 老年人面临心理健康问题的风险增加,包括焦虑,抑郁和痴呆.
- 抑郁症对老年人的生活质量和寿命有重大影响.
研究的目的:
- 根据抑郁症的严重程度,估计中国老年人的预期寿命 (LE) 和没有抑郁症的预期寿命 (DFLE).
- 根据性别和Hukou (农村/城市) 地位分析LE和DFLE的差异.
主要方法:
- 利用了2011-2020年中国健康与退休长度研究 (CHARLS) 的数据 (n=2,185).
- 应用了多状态生命表方法来计算LE和DFLE,按抑郁症严重程度,性别和Hukou状态分层.
- 采用Z测试来确定观察到的差异的统计学意义 (p<0.05).
主要成果:
- 在65岁时,整体LE为25.39年,其中15.61年没有抑郁症.
- 中度至重度抑郁症将LE降低到3.59年;轻度抑郁症将其降低到6.19年.
- 城市老年人的LE (26.47岁) 和DFLE (18.04岁) 比农村老年人 (LE 24.74,DFLE 14.23岁) 高.
- 与男性相比,女性的LE时间较长 (25.81年),但DFLE时间较短 (14.30年) (LE 24.91,DFLE 16.91年).
结论:
- 城市老年人经验优越的寿命和生活质量,可能是由于更好的心理健康资源的可访问性.
- 在DFLE的性别差异表明女性的心理负担或健康不平等可能更高.
- 中度至重度的抑郁症与死亡率增加和恢复率降低有关,特别是在80岁后.
相关概念视频
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Depressive Disorders: MDD and Dysthymia
627
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
627
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
233
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233


